Literature DB >> 22881119

The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1.

Karen Lidzba1, Sofia Granström, Jorge Lindenau, Victor-Felix Mautner.   

Abstract

AIM: A substantial proportion of patients with neurofibromatosis type 1 (NF1) have attention-deficit disorder with or without hyperactivity (AD[H]D). This study explored the influence of AD(H)D symptoms on the intellectual profile of patients with NF1.
METHOD: We retrospectively analysed neuropsychological data from 114 children (66 males, 48 females; age range 6-16y; mean age 9y 3mo [SE 3mo]) with NF1 from an NF1 outpatients department. Assessment included psychiatric diagnosis of AD(H)D (DSM-IV-TR criteria) and intelligence testing (Wechsler Intelligence Scale for Children, German version). Magnetic resonance images were available for all patients, intracranial findings being an exclusion criterion. The effects of AD(H)D symptoms on intelligence and on the cognitive profile were tested by analyses of variance.
RESULTS: Patients with AD(H)D symptoms performed significantly worse than those without AD(H)D symptoms on all intelligence measures (main effects for Full-scale, Verbal, and Performance IQ; p<0.005). Subtests typically impaired in patients with NF1 (visuospatial skills and arithmetic) were not specifically influenced by AD(H)D symptoms. There were no differences between AD(H)D subtypes.
INTERPRETATION: AD(H)D symptoms have a negative impact on the intellectual development of children with NF1. This impact seems to be of an unspecific nature, with a general attenuation of the cognitive profile. © The Authors. Developmental Medicine & Child Neurology
© 2012 Mac Keith Press.

Entities:  

Mesh:

Year:  2012        PMID: 22881119     DOI: 10.1111/j.1469-8749.2012.04377.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  21 in total

1.  Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1.

Authors:  Sandra P Toelle; Andrea Poretti; Peter Weber; Tatjana Seute; Jacoline E C Bromberg; Ianina Scheer; Eugen Boltshauser
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

2.  Neurofibromatosis Type 1 Implicates Ras Pathways in the Genetic Architecture of Neurodevelopmental Disorders.

Authors:  Jessica A Kaczorowski; Taylor F Smith; Amanda M Shrewsbury; Leah R Thomas; Valerie S Knopik; Maria T Acosta
Journal:  Behav Genet       Date:  2020-02-05       Impact factor: 2.805

3.  Parent-Reported Social Skills in Children with Neurofibromatosis Type 1: Longitudinal Patterns and Relations with Attention and Cognitive Functioning.

Authors:  Danielle M Glad; Christina L Casnar; Brianna D Yund; Kristin Lee; Bonita P Klein-Tasman
Journal:  J Dev Behav Pediatr       Date:  2021 Oct-Nov 01       Impact factor: 2.225

4.  Quality of Life in Adults with Neurofibromatosis 1 in Brazil.

Authors:  Natália Parenti Bicudo; Balduíno Ferreira de Menezes Neto; Lucimar Retto da Silva de Avó; Carla Maria Ramos Germano; Débora Gusmão Melo
Journal:  J Genet Couns       Date:  2016-03-05       Impact factor: 2.537

Review 5.  An executive functioning perspective in neurofibromatosis type 1: from ADHD and autism spectrum disorder to research domains.

Authors:  Taylor F Smith; Jessica A Kaczorowski; Maria T Acosta
Journal:  Childs Nerv Syst       Date:  2020-07-03       Impact factor: 1.475

6.  Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis.

Authors:  Chinwe C Madubata; Margaret A Olsen; Dustin L Stwalley; David H Gutmann; Kimberly J Johnson
Journal:  Genet Med       Date:  2014-06-05       Impact factor: 8.822

7.  Measurement of the effect of physical exercise on the concentration of individuals with ADHD.

Authors:  Alessandro P Silva; Sueli O S Prado; Terigi A Scardovelli; Silvia R M S Boschi; Luiz C Campos; Annie F Frère
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

Review 8.  Using Sibling Designs to Understand Neurodevelopmental Disorders: From Genes and Environments to Prevention Programming.

Authors:  Mark Wade; Heather Prime; Sheri Madigan
Journal:  Biomed Res Int       Date:  2015-07-15       Impact factor: 3.411

9.  Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.

Authors:  Maria J Ribeiro; Otília C d'Almeida; Fabiana Ramos; Jorge Saraiva; Eduardo D Silva; Miguel Castelo-Branco
Journal:  J Neurodev Disord       Date:  2014-02-21       Impact factor: 4.025

10.  The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial.

Authors:  Laurence Lion-François; François Gueyffier; Catherine Mercier; Daniel Gérard; Vania Herbillon; Isabelle Kemlin; Diana Rodriguez; Tiphanie Ginhoux; Emeline Peyric; Virginie Coutinho; Valentine Bréant; Vincent des Portes; Stéphane Pinson; Patrick Combemale; Behrouz Kassaï
Journal:  Orphanet J Rare Dis       Date:  2014-09-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.